Try our beta test site
1 study found for:    18701491 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML
Conditions: Acute Myeloid Leukemia;   AML
Intervention: Drug: Tosedostat

Study has passed its completion date and status has not been verified in more than two years.